Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

High-risk Human Papillomavirus Genotype Detection by Electrochemical DNA Chip Method

  • Published : 2012.04.30
Download PDF
⟨ Previous Next ⟩

Abstract

High-risk human papillomavirus (HPV) genotypes are the major cause of cervical cancer. Hence, HPV genotype detection is a helpful preventive measure to combat cervical cancer. Recently, several HPV detection methods have been developed, each with different sensitivities and specificities. The objective of this study was to compare HPV high risk genotype detection by an electrochemical DNA chip system, a line probe assay (INNO-LiPA) and sequencing of the L1, E1 regions. A total of 361 cervical smears with different cytological findings were subjected to polymerase chain reaction-sequencing and electrochemical DNA chip assessment. Multiple infections were found in 21.9% (79/361) of the specimens, most prevalently in 20-29-year olds while the highest prevalence of HPV infection was found in the 30-39-year age group. The most prevalent genotype was HPV 16 at 28.2% (138/489) followed by HPV 52 at 9.6% (47/489), with the other types occurring at less than 9.0%. The electrochemical DNA chip results were compared with INNO-LiPA and sequencing (E1 and L1 regions) based on random selection of 273 specimens. The results obtained by the three methods were in agreement except for three cases. Direct sequencing detected only one predominant genotype including low risk HPV genotypes. INNO-LiPA identified multiple infections with various specific genotypes including some unclassified-risk genotypes. The electrochemical DNA chip was highly accurate, suitable for detection of single and multiple infections, allowed rapid detection, was less time-consuming and was easier to perform when compared with the other methods. It is concluded that for clinical and epidemiological studies, all genotyping methods are perfectly suitable and provide comparable results.

Keywords

References

  1. Castle PE, Solomon D, Wheeler CM, et al (2008). Human papillomavirus genotype specificity of hybrid capture 2. J Clin Microbiol, 46, 2595-604. https://doi.org/10.1128/JCM.00824-08
  2. Chan PK, Lam CW, Cheung TH, et al (2002). Association of human papillomavirus type 58 variant with the risk of cervical cancer. J Natl Cancer Inst, 94, 1249-53. https://doi.org/10.1093/jnci/94.16.1249
  3. Chansaenroj J, Lurchachaiwong W, Termrungruanglert W, et al (2010). Prevalence and genotypes of human papillomavirus among Thai women. Asian Pac J Cancer Prev, 11, 117-22.
  4. Chumworathayi B, Thinkhamrop J, Blumenthal PD, et al (2010). Cryotherapy for HPV clearance in women with biopsyconfirmed cervical low-grade squamous intraepithelial lesions. Int J Gynaecol Obstet, 108, 119-22. https://doi.org/10.1016/j.ijgo.2009.09.012
  5. Clifford GM, Gallus S, Herrero R, et al (2005). Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet, 366, 991-8. https://doi.org/10.1016/S0140-6736(05)67069-9
  6. Clifford GM, Rana RK, Franceschi S, et al (2005). Human papillomavirus genotype distribution in low-grade cervical lesions: comparison by geographic region and with cervical cancer. Cancer Epidemiol Biomarkers Prev, 14, 1157-64. https://doi.org/10.1158/1055-9965.EPI-04-0812
  7. Cope JU, Hildesheim A, Schiffman MH, et al (1997). Comparison of the hybrid capture tube test and PCR for detection of human papillomavirus DNA in cervical specimens. J Clin Microbiol, 35, 2262-5.
  8. Cuzick J (2002). Role of HPV testing in clinical practice. Virus Res, 89, 263-9. https://doi.org/10.1016/S0168-1702(02)00194-6
  9. Cuzick J, Szarewski A, Terry G, et al (1995). Human papillomavirus testing in primary cervical screening. Lancet, 345, 1533-6. https://doi.org/10.1016/S0140-6736(95)91086-7
  10. Federschneider JM, Yuan L, Brodsky J, et al (2004). The borderline or weakly positive Hybrid Capture II HPV test: a statistical and comparative (PCR) analysis. Am J Obstet Gynecol, 191, 757-61. https://doi.org/10.1016/j.ajog.2004.03.077
  11. Galan-Sanchez F, Rodriguez-Iglesias MA (2009). Comparison of human papillomavirus genotyping using commercial assays based on PCR and reverse hybridization methods. APMIS, 117, 708-15. https://doi.org/10.1111/j.1600-0463.2009.02522.x
  12. Gravitt PE, Peyton CL, Alessi TQ, et al (2000). Improved amplification of genital human papillomaviruses. J Clin Microbiol, 38, 357-61.
  13. Herrero R, Castle PE, Schiffman M, et al (2005). Epidemiologic profile of type-specific human papillomavirus infection and cervical neoplasia in Guanacaste, Costa Rica. J Infect Dis, 191, 1796-807. https://doi.org/10.1086/428850
  14. Ho GY, Bierman R, Beardsley L, et al (1998). Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med, 338, 423-8. https://doi.org/10.1056/NEJM199802123380703
  15. Karlsen F, Kalantari M, Jenkins A, et al (1996). Use of multiple PCR primer sets for optimal detection of human papillomavirus. J Clin Microbiol, 34, 2095-100.
  16. Koutsky L (1997). Epidemiology of genital human papillomavirus infection. Am J Med, 102, 3-8.
  17. Klug SJ, Molijn A, Schopp B, et al (2008). Comparison of the performance of different HPV genotyping methods for detecting genital HPV types. J Med Virol, 80, 1264-74. https://doi.org/10.1002/jmv.21191
  18. Lai HC, Sun CA, Yu MH, et al (1999). Favorable clinical outcome of cervical cancers infected with human papilloma virus type 58 and related types. Int J Cancer, 84, 553-7. https://doi.org/10.1002/(SICI)1097-0215(19991222)84:6<553::AID-IJC2>3.0.CO;2-4
  19. Li Y, Li Z, He Y, et al (2009). Phylogeographic analysis of human papillomavirus 58. Sci China C Life Sci, 52, 1164-72. https://doi.org/10.1007/s11427-009-0149-6
  20. Lurchachaiwong W, Junyangdikul P, Payungporn S, et al (2009). Relationship between hybrid capture II ratios and DNA amplification of E1, E6 and L1 genes used for the detection of human papillomavirus in samples with different cytological findings. Asian Pac J Allergy Immunol, 27, 217-24.
  21. Matsukura T, Sugase M (2004). Human papillomavirus genomes in squamous cell carcinomas of the uterine cervix. Virology, 324, 439-49. https://doi.org/10.1016/j.virol.2004.03.017
  22. Melnikow J, Nuovo J, Willan AR, et al (1998). Natural history of cervical squamous intraepithelial lesions: a meta-analysis. Obstet Gynecol, 92, 727-35. https://doi.org/10.1016/S0029-7844(98)00245-2
  23. Miura S, Matsumoto K, Oki A, et al (2006). Do we need a different strategy for HPV screening and vaccination in East Asia? Int J Cancer, 119, 2713-5. https://doi.org/10.1002/ijc.22195
  24. Munoz N (2000). Human papillomavirus and cancer: the epidemiological evidence. J Clin Virol, 19, 1-5. Review. https://doi.org/10.1016/S1386-6532(00)00125-6
  25. Munoz N, Bosch FX, De Sanjose S, et al (2003). Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med, 348, 518-27. https://doi.org/10.1056/NEJMoa021641
  26. Peto J, Gilham C, Deacon J, et al (2004). Cervical HPV infection and neoplasia in a large population-based prospective study: the Manchester cohort. Br J Cancer, 91, 942-53.
  27. Plummer M, Schiffman M, Castle PE, et al (2007). A 2-year prospective study of human papillomavirus persistence among women with a cytological diagnosis of atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion. J Infect Dis, 195, 1582-9. https://doi.org/10.1086/516784
  28. Resnick RM, Cornelissen MT, Wright DK, et al (1990). Detection and typing of human papillomavirus in archival cervical cancer specimens by DNA amplification with consensus primers. J Natl Cancer Inst, 82, 1477-84. https://doi.org/10.1093/jnci/82.18.1477
  29. Rousseau MC, Villa LL, Costa MC, et al (2003). Occurrence of cervical infection with multiple human papillomavirus types is associated with age and cytologic abnormalities. Sex Transm Dis, 30, 581-7. https://doi.org/10.1097/00007435-200307000-00010
  30. Sasagawa T, Basha W, Yamazaki H, et al (2001). High-risk and multiple human papillomavirus infections associated with cervical abnormalities in Japanese women. Cancer Epidemiol Biomarkers Prev, 10, 45-52.
  31. Schiffman MH, Bauer HM, Hoover RN, et al (1993). Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst, 85, 958-64. https://doi.org/10.1093/jnci/85.12.958
  32. Schlecht NF, Platt RW, Duarte-Franco E, et al (2003). Human papillomavirus infection and time to progression and regression of cervical intraepithelial neoplasia. J Natl Cancer Inst, 95, 1336-43. https://doi.org/10.1093/jnci/djg037
  33. Seme K, Fujs K, Kocjan BJ, et al (2006). Resolving repeatedly borderline results of Hybrid Capture 2 HPV DNA Test using polymerase chain reaction and genotyping. J Virol Methods, 134, 252-6. https://doi.org/10.1016/j.jviromet.2005.12.004
  34. Shadrina MI, Semenova EV, Slominsky PA, et al (2007). Effective quantitative real-time polymerase chain reaction analysis of the parkin gene (PARK2) exon 1-12 dosage. BMC Med Genet, 8, 6.
  35. Smith JS, Lindsay L, Hoots B, et al (2007). Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer, 121, 621-32. https://doi.org/10.1002/ijc.22527
  36. Snijders PJ, van den Brule AJ, Meijer CJ (2003). The clinical relevance of human papillomavirus testing: relationship between analytical and clinical sensitivity. J Pathol, 201, 1-6. https://doi.org/10.1002/path.1433
  37. Sotlar K, Diemer D, Dethleffs A, et al (2004). Detection and typing of human papillomavirus by e6 nested multiplex PCR. J Clin Microbiol, 42, 3176-84. https://doi.org/10.1128/JCM.42.7.3176-3184.2004
  38. Terry G, Ho L, Londesborough P, et al (2001). Detection of high-risk HPV types by the hybrid capture 2 test. J Med Virol, 65, 155-62. https://doi.org/10.1002/jmv.2015
  39. Trottier H, Mahmud S, Costa MC, et al (2006). Human papillomavirus infections with multiple types and risk of cervical neoplasia. Cancer Epidemiol Biomarkers Prev, 15, 1274-80. https://doi.org/10.1158/1055-9965.EPI-06-0129
  40. Tsao KC, Huang CG, Kuo YB, et al (2010). Prevalence of human papillomavirus genotypes in northern Taiwanese women. J Med Virol, 82, 1739-45. https://doi.org/10.1002/jmv.21870
  41. Tucker RA, Johnson PR, Reeves WC, et al (1993). Using the polymerase chain reaction to genotype human papillomavirus DNAs in samples containing multiple HPVs may produce inaccurate results. J Virol Methods, 43, 321-33. https://doi.org/10.1016/0166-0934(93)90150-P
  42. Vizcaino AP, Moreno V, Bosch FX, et al (2000). International trends in incidence of cervical cancer: II. Squamous-cell carcinoma. Int J Cancer, 86, 429-35. https://doi.org/10.1002/(SICI)1097-0215(20000501)86:3<429::AID-IJC20>3.0.CO;2-D
  43. Wright TC Jr, Cox JT, Massad LS, et al (2001) Consensus Guidelines for the management of women with cervical cytological abnormalities. JAMA, 287, 2120-9.
  44. Wright TC Jr, Schiffman M, Solomon D, et al (2004). Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening. Obstet Gynecol, 103, 304-9. https://doi.org/10.1097/01.AOG.0000109426.82624.f8

Cited by

  1. Large scale study of HPV genotypes in cervical cancer and different cytological cervical specimens in Thailand vol.86, pp.4, 2014, https://doi.org/10.1002/jmv.23769
  2. The Aetiological Role of Human Papillomavirus in Colorectal Carcinoma: An Iranian Population- Based Case Control Study vol.15, pp.4, 2014, https://doi.org/10.7314/APJCP.2014.15.4.1521
  3. In Vivo and In Vitro Studies Suggest a Possible Involvement of HPV Infection in the Early Stage of Breast Carcinogenesis via APOBEC3B Induction vol.9, pp.5, 2014, https://doi.org/10.1371/journal.pone.0097787
  4. Comparison of Detection Sensitivity for Human Papillomavirus between Self-collected Vaginal Swabs and Physician-collected Cervical Swabs by Electrochemical DNA Chip vol.15, pp.24, 2015, https://doi.org/10.7314/APJCP.2014.15.24.10809
  5. Comparison of Four Human Papillomavirus Genotyping Methods: Next-generation Sequencing, INNO-LiPA, Electrochemical DNA Chip, and Nested-PCR vol.38, pp.2, 2018, https://doi.org/10.3343/alm.2018.38.2.139